| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product Name |
Levetiracetam |
Synonyms |
Levetiracetam Powder |
| CAS | 102767-28-2 |
| MF | C8H14N2O2 |
| MW | 170.20896 |
| Purity | 99% HPLC |
| Appearance | white crystalline powder |
| Certification | USP, BP, GMP |
| Standard | Enterprise standard |
| Grade | Pharmaceutical grade |
| Usage | Antiepileptic |
| Storage | Store in a cool and dry area and keep away from direct sunlight |
Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic
seizures. Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of
partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown
to reduce partial (focal) seizures by 50% or more as an add-on medication.It is also used in veterinary medicine for similar
purposes. Based on low-quality evidence, levetiracetam is about as effective as phenytoin for prevention of early seizures
after traumatic brain injury.
Levetiracetam is suitable for assistant treatment of partial or secondary generalized epileptic seizures in adult epilepsy patients.
1) Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case
of partial seizures
2) Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome
3) It is also sometimes used to treat neuropathic pain
){kind=link}